Iovance Biotherapeutics (IOVA) to Release Quarterly Earnings on Thursday
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) is projected to announce its Q1 2025 earnings results after the market closes on Thursday, May 8th. Analysts expect the company to post earnings of ($0.25) per share and revenue of $83.40 million for the quarter. Iovance Biotherapeutics has set its FY 2025 guidance at EPS. Iovance Biotherapeutics […]
